Could a brain cancer drug target tumor activity? early trial launches
Disease control
Recruiting now
This early-phase trial tests the drug troriluzole in 27 adults with recurrent IDH wild-type glioblastoma, an aggressive brain cancer. Participants take the drug before surgery, and researchers measure brain activity and glutamate levels in the removed tumor tissue. The goal is to…
Phase: EARLY_PHASE1 • Sponsor: Ugonma Chukwueke • Aim: Disease control
Last updated Jun 26, 2026 16:51 UTC